|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain E:
E.C.3.4.21.62
- subtilisin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. Hydrolyzes peptide amides.
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain I:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
99:10316-10321
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
A clogged gutter mechanism for protease inhibitors.
|
|
E.S.Radisky,
D.E.Koshland.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A classical peptide inhibitor of serine proteases that is hydrolyzed
approximately 10(7) times more slowly than a good substrate is shown to form an
acyl-enzyme intermediate rapidly. Despite this quick first step, further
reaction is slowed dramatically because of tight and oriented binding of the
cleaved peptide, preventing acyl-enzyme hydrolysis and favoring the reverse
reaction. Moreover, this mechanism appears to be common to a large class of
tight-binding serine protease inhibitors that mimic good substrates. The arrest
of enzymatic reaction at the intermediate stage allowed us to determine that the
consensus nucleophilic attack angle is close to 90 degrees in the reactive
Michaelis complexes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig 3. (A) Ribbon diagram of subtilisin/CI2 complex
structure. Subtilisin is shown in red, the N-terminal section of
CI2 is shown in dark blue, and the C-terminal section of CI2 is
shown in light blue. The reactive site peptide bond is at the
junction of the dark and light blue segments. (B) Closer view of
reactive site loop. CI2 side chains (labeled in white) and
hydrogen bonds (yellow dotted lines) proposed to stabilize the
positioning of the light blue (leaving group) side of the loop
after acyl-enzyme formation (see text) are shown in detail. The
serine, histidine, and aspartate of the subtilisin catalytic
triad are also shown (labeled in yellow).
|
 |
Figure 4.
Fig 4. Nucleophilic attack trajectories for
protease/inhibitor complexes. (A) The geometric parameters
describing the nucleophilic attack trajectory are
diagrammatically defined. [y] is the angle defined
by the enzyme serine -oxygen, the inhibitor
carbonyl carbon, and the inhibitor carbonyl oxygen. [x] is
the angle between (i) the plane defined by the enzyme serine
-oxygen, the inhibitor
carbonyl carbon, and the inhibitor carbonyl oxygen, and (ii) the
plane defined by the peptide bond. O--C represents the
distance between the enzyme serine -oxygen and the inhibitor
carbonyl carbon. (B) Plot of [y] vs. [x]. Blue
triangles represent the structures of 78 protease/inhibitor
complexes, the orange circle represents the subtilisin/CI2
complex, and the red square represents the thrombin/fibrinogen
analog structure (16). The peptide bond diagrammed in the
background is for illustrative purposes. (C and D) Two views of
the superposition of 79 protease/inhibitor complexes, including
subtilisin/CI2. Superpositioning was based on the -carbon
and carbonyl oxygen of the P[1] residue, and the amide nitrogen
of the P residue,
which overlay closely for all structures. The red spheres
represent the relative positions of the enzyme serine -oxygen
for each structure. The outlying structure apparent in B, C, and
D is that of an ecotin mutant complexed with trypsin.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.Johnston,
C.R.Søndergaard,
and
J.E.Nielsen
(2011).
Integrated prediction of the effect of mutations on multiple protein characteristics.
|
| |
Proteins,
79,
165-178.
|
 |
|
|
|
|
 |
M.Gamble,
G.Künze,
E.J.Dodson,
K.S.Wilson,
and
D.D.Jones
(2011).
Regulation of an intracellular subtilisin protease activity by a short propeptide sequence through an original combined dual mechanism.
|
| |
Proc Natl Acad Sci U S A,
108,
3536-3541.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Whitley,
and
A.L.Lee
(2011).
Exploring the role of structure and dynamics in the function of chymotrypsin inhibitor 2.
|
| |
Proteins,
79,
916-924.
|
 |
|
|
|
|
 |
H.Hwang,
T.Vreven,
B.G.Pierce,
J.H.Hung,
and
Z.Weng
(2010).
Performance of ZDOCK and ZRANK in CAPRI rounds 13-19.
|
| |
Proteins,
78,
3104-3110.
|
 |
|
|
|
|
 |
J.Vévodová,
M.Gamble,
G.Künze,
A.Ariza,
E.Dodson,
D.D.Jones,
and
K.S.Wilson
(2010).
Crystal structure of an intracellular subtilisin reveals novel structural features unique to this subtilisin family.
|
| |
Structure,
18,
744-755.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.A.Salameh,
J.L.Robinson,
D.Navaneetham,
D.Sinha,
B.J.Madden,
P.N.Walsh,
and
E.S.Radisky
(2010).
The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.
|
| |
J Biol Chem,
285,
1939-1949.
|
 |
|
|
|
|
 |
M.Krzeminski,
K.Loth,
R.Boelens,
and
A.M.Bonvin
(2010).
SAMPLEX: automatic mapping of perturbed and unperturbed regions of proteins and complexes.
|
| |
BMC Bioinformatics,
11,
51.
|
 |
|
|
|
|
 |
R.Ganesan,
C.Eigenbrot,
and
D.Kirchhofer
(2010).
Structural and mechanistic insight into how antibodies inhibit serine proteases.
|
| |
Biochem J,
430,
179-189.
|
 |
|
|
|
|
 |
S.Khamrui,
S.Majumder,
J.Dasgupta,
J.K.Dattagupta,
and
U.Sen
(2010).
Identification of a novel set of scaffolding residues that are instrumental for the inhibitory property of Kunitz (STI) inhibitors.
|
| |
Protein Sci,
19,
593-602.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Zakharova,
M.P.Horvath,
and
D.P.Goldenberg
(2009).
Structure of a serine protease poised to resynthesize a peptide bond.
|
| |
Proc Natl Acad Sci U S A,
106,
11034-11039.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.S.Siddiqui,
D.M.Parkin,
P.M.Curmi,
D.De Francisci,
A.Poljak,
K.Barrow,
M.H.Noble,
J.Trewhella,
and
R.Cavicchioli
(2009).
A novel approach for enhancing the catalytic efficiency of a protease at low temperature: reduction in substrate inhibition by chemical modification.
|
| |
Biotechnol Bioeng,
103,
676-686.
|
 |
|
|
|
|
 |
E.Zakharova,
M.P.Horvath,
and
D.P.Goldenberg
(2008).
Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor.
|
| |
J Mol Biol,
382,
998.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Singh,
S.A.Williams,
M.H.Shah,
T.Lectka,
G.J.Pritchard,
J.T.Isaacs,
and
S.R.Denmeade
(2008).
Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds.
|
| |
Proteins,
70,
1416-1428.
|
 |
|
|
|
|
 |
J.L.Wheatley,
and
T.Holyoak
(2007).
Differential P1 arginine and lysine recognition in the prototypical proprotein convertase Kex2.
|
| |
Proc Natl Acad Sci U S A,
104,
6626-6631.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.M.Hanson,
G.J.Domek,
M.P.Horvath,
and
D.P.Goldenberg
(2007).
Rigidification of a flexible protease inhibitor variant upon binding to trypsin.
|
| |
J Mol Biol,
366,
230-243.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.S.Radisky,
J.M.Lee,
C.J.Lu,
and
D.E.Koshland
(2006).
Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates.
|
| |
Proc Natl Acad Sci U S A,
103,
6835-6840.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Shen,
M.H.Tatham,
C.Dong,
A.Zagórska,
J.H.Naismith,
and
R.T.Hay
(2006).
SUMO protease SENP1 induces isomerization of the scissile peptide bond.
|
| |
Nat Struct Mol Biol,
13,
1069-1077.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Jäger,
E.Nir,
and
S.Weiss
(2006).
Site-specific labeling of proteins for single-molecule FRET by combining chemical and enzymatic modification.
|
| |
Protein Sci,
15,
640-646.
|
 |
|
|
|
|
 |
R.Helland,
A.N.Larsen,
A.O.Smalås,
and
N.P.Willassen
(2006).
The 1.8 A crystal structure of a proteinase K-like enzyme from a psychrotroph Serratia species.
|
| |
FEBS J,
273,
61-71.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Otlewski,
F.Jelen,
M.Zakrzewska,
and
A.Oleksy
(2005).
The many faces of protease-protein inhibitor interaction.
|
| |
EMBO J,
24,
1303-1310.
|
 |
|
|
|
|
 |
J.T.Maynes,
M.M.Cherney,
M.A.Qasim,
M.Laskowski,
and
M.N.James
(2005).
Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
580-588.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.P.Silva,
R.B.Azevedo,
P.C.Morais,
M.M.Ventura,
and
S.M.Freitas
(2005).
Oligomerization states of Bowman-Birk inhibitor by atomic force microscopy and computational approaches.
|
| |
Proteins,
61,
642-648.
|
 |
|
|
|
|
 |
M.Jäger,
X.Michalet,
and
S.Weiss
(2005).
Protein-protein interactions as a tool for site-specific labeling of proteins.
|
| |
Protein Sci,
14,
2059-2068.
|
 |
|
|
|
|
 |
T.M.Schmeing,
K.S.Huang,
S.A.Strobel,
and
T.A.Steitz
(2005).
An induced-fit mechanism to promote peptide bond formation and exclude hydrolysis of peptidyl-tRNA.
|
| |
Nature,
438,
520-524.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |